INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
SM
Corporate insider

Secora Michael

CFO & Chief Corp Dev OfcrCIK 0001855980

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 0
Max Insider Score17
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
SM
Secora MichaelCFO & Chief Corp Dev Ofcr
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
61.3K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Iambic Therapeutics, Inc.CFO & Chief Corp Dev Ofcr · Oct 16, 2026
9
SM
Secora MichaelCFO & Chief Corp Dev Ofcr
IAMIambic Therapeutics, Inc.
Derivative conversion
C
—
61.3K sh
Oct 16, 2026
Oct 19, 2026
traded Oct 16, 2026
+3d
SEC FORM 4

Evidence

13
SM
Secora MichaelCFO & Chief Corp Dev Ofcr
IAMIambic Therapeutics, Inc.
Grant or award
A—
28.4K sh
Oct 14, 2026Oct 16, 2026
traded Oct 14, 2026
+2dSEC FORM 4

Evidence

9
SM
Secora MichaelCFO & Chief Corp Dev Ofcr
IAMIambic Therapeutics, Inc.
Grant or award
A—
170.3K sh
Oct 14, 2026Oct 16, 2026
traded Oct 14, 2026
+2dSEC FORM 4

Evidence